Analysed BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) News Sources
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
13-03-2026
yahoo.com
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?
15-12-2025
yahoo.com
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
10-12-2025
yahoo.com
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
07-11-2025
yahoo.com
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
24-10-2025
yahoo.com
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
30-09-2025
yahoo.com
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
07-08-2025
yahoo.com
What is the current price of BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ)?
The current price of BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) is $0.5675.
BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) absolute price change since previous trading day?
The absolute price change of BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) since the previous trading day is $0.0175.
BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) percentage price change since previous trading day?
The percentage price change of BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) since the previous trading day is 3.1818%.
What is the most recent average sentiment score for BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ)?
The most recent average sentiment score for BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ)?
The most recent sentiment for BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ) is .
SEC-8K** Filing Available For BARINTHUS BIOTHERAPEUTICS PL (BRNS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.